<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03000582</url>
  </required_header>
  <id_info>
    <org_study_id>IRB2014-0362F</org_study_id>
    <nct_id>NCT03000582</nct_id>
  </id_info>
  <brief_title>Assessment of Different Forms of Creatine</brief_title>
  <acronym>NB3</acronym>
  <official_title>Pharmacokinetic Assessment of Acute Ingestion of Different Forms of Creatine</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Texas A&amp;M University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Nutrabolt</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Texas A&amp;M University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to examine the pharmacokinetics of creatine nitrate
      supplementation.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Creatine nitrate contains several nutrients that may increase anaerobic exercise performance.
      Theoretically, dietary supplementation of creatine nitrate during resistance training can
      improve the quality of training leading to greater changes in strength, power and fat free
      mass. Endothelial function measured by flow-mediated dilation (FMD), a non-invasive vascular
      health parameter that can be measured via ultrasonography, is a predictor of cardiovascular
      disease risk which precedes traditional risk markers. Diet, physical activity and
      pharmaceutical interventions can all impact vascular function and health. The purpose of this
      study is to determine the acute vascular response of creatine nitrate supplementation on FMD
      by analyzing the pharmacokinetics of creatine nitrate supplementation.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2014</start_date>
  <completion_date type="Actual">September 2014</completion_date>
  <primary_completion_date type="Actual">September 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Examine creatine vs. creatine nitrate supplementation by assessing body water</measure>
    <time_frame>One day</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Examine creatine vs. creatine nitrate supplementation by assessing body composition</measure>
    <time_frame>One day</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Examine creatine vs. creatine nitrate supplementation by assessing serum creatine levels</measure>
    <time_frame>One day</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Examine creatine vs. creatine nitrate supplementation by assessing serum nitrate levels</measure>
    <time_frame>One day</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Examine creatine vs. creatine nitrate supplementation by assessing serum nitrite levels</measure>
    <time_frame>One day</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Examine creatine vs. creatine nitrate supplementation by assessing flow-mediated dilation (FMD) via ultrasonography</measure>
    <time_frame>One day</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Measure standard clinical chemistry panels in the blood to evaluate safety</measure>
    <time_frame>One day</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Measure side effects to evaluate safety utilizing a side effects questionnaire</measure>
    <time_frame>One day</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Measure heart rate to evaluate safety</measure>
    <time_frame>One day</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Measure blood pressure to evaluate safety</measure>
    <time_frame>One day</time_frame>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">13</enrollment>
  <condition>Dietary Modification</condition>
  <arm_group>
    <arm_group_label>Creatine monohydrate</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>5 gm creatine monohydrate, 1.5 gm dextrose</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Creatine nitrate-1</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>1 gm creatine monohydrate, 0.5 gm nitrate, 5 gm dextrose</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Creatine nitrate-2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>2 gm creatine monohydrate, 1 gm nitrate, 3.5 gm dextrose</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>6.5 gm dextrose</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Creatine monohydrate</intervention_name>
    <description>Creatine monohydrate (5.0 g creatine monohydrate, 1.5 g dextrose)</description>
    <arm_group_label>Creatine monohydrate</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Creatine nitrate-1</intervention_name>
    <description>Creatine nitrate-1 (1.0 g creatine monohydrate, 0.5 g nitrate, 5.0 g dextrose)</description>
    <arm_group_label>Creatine nitrate-1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Creatine nitrate-2</intervention_name>
    <description>Creatine nitrate-2 (2.0 g creatine monohydrate, 1.0 g nitrate, 3.5 g dextrose)</description>
    <arm_group_label>Creatine nitrate-2</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Placebo (6.5 g dextrose)</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  you are an apparently healthy and recreationally active male between the ages of 18
             and 40;

        Exclusion Criteria:

          -  you have a history of treatment for metabolic disease (i.e., diabetes), hypertension,
             hypotension, thyroid disease, arrhythmia and/or cardiovascular disease;

          -  you are currently using prescription medications;

          -  you have a history of smoking;

          -  you drink excessively (i.e., 12 drinks per week or more);

          -  you have a recent history of creatine supplementation within six weeks of the start of
             supplementation;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <verification_date>December 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 14, 2016</study_first_submitted>
  <study_first_submitted_qc>December 19, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 22, 2016</study_first_posted>
  <last_update_submitted>December 19, 2016</last_update_submitted>
  <last_update_submitted_qc>December 19, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 22, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

